Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/8876
Full metadata record
DC FieldValueLanguage
dc.rights.licenseBY-NC-ND-
dc.contributor.authorVulović D.-
dc.contributor.authorSreckovic M.-
dc.contributor.authorPetrovic, Nenad-
dc.contributor.authorPetrovic M.-
dc.contributor.authorJovanovic, Svetlana-
dc.contributor.authorTodorovic, Danijela-
dc.date.accessioned2020-09-19T16:54:32Z-
dc.date.available2020-09-19T16:54:32Z-
dc.date.issued2017-
dc.identifier.issn0350-1221-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/8876-
dc.description.abstract© 2017, Serbian Medical Society. All rights reserved. Retinopathy of prematurity is a proliferative retinopathy that occurs in prematurely born children. It is still the leading cause of preventable childhood blindness worldwide. The aim of this paper is to present the therapeutic modalities for the retinopathy of prematurity. Current gold standard treatment is the laser photocoagulation of avascular retina in order to reduce its existing hypoxia. By expanding our knowledge of the pathogenesis of рetinopathy of prematurity, and the knowledge of the laser therapy efficiency and complications as well, new therapeutic options appear (intravitreal application of anti VEGF, gene therapy and administration of supplements). In order to avoid the visual function loss in prematures caused by retinopathy of prematurity, screening of the premature newborn is the first choice.-
dc.rightsopenAccess-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.sourceMedicinski Casopis-
dc.titleModern approach to the retinopathy of prematurity treatment-
dc.typearticle-
dc.identifier.doi10.5937/mckg51-16428-
dc.identifier.scopus2-s2.0-85044715426-
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

164

Downloads(s)

109

Files in This Item:
File Description SizeFormat 
10.5937-mckg51-16428.pdf266.69 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons